Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders.


Journal

Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602

Informations de publication

Date de publication:
09 01 2019
Historique:
received: 28 08 2018
accepted: 28 12 2018
entrez: 11 1 2019
pubmed: 11 1 2019
medline: 7 5 2019
Statut: epublish

Résumé

Chylothorax is a rare condition which can be associated with malignant lymphoproliferative disorders (LPDs). We retrospectively analyzed the results of the conservative treatment of 10 patients with persistent non-traumatic malignant chylothorax. Conservative treatment lead to a decline of chylothorax after mean of 66 days and consisted of the treatment of the underlying disease and of simultaneous long-term supportive care (drainage of the thoracic cavity, dietary measures and nutrition management). In most cases (80%), chylothorax disappeared only after a successful therapeutic response of the underlying disease. Low-dose radiotherapy had very good effects in two patients. Conservative treatment of malignant chylothorax can be considered a suitable method. Based on our results, successful treatment of the lymphoproliferative disorder seems to be a very important factor for the disappearance of chylothorax.

Sections du résumé

BACKGROUND
Chylothorax is a rare condition which can be associated with malignant lymphoproliferative disorders (LPDs). We retrospectively analyzed the results of the conservative treatment of 10 patients with persistent non-traumatic malignant chylothorax.
RESULTS
Conservative treatment lead to a decline of chylothorax after mean of 66 days and consisted of the treatment of the underlying disease and of simultaneous long-term supportive care (drainage of the thoracic cavity, dietary measures and nutrition management). In most cases (80%), chylothorax disappeared only after a successful therapeutic response of the underlying disease. Low-dose radiotherapy had very good effects in two patients.
CONCLUSION
Conservative treatment of malignant chylothorax can be considered a suitable method. Based on our results, successful treatment of the lymphoproliferative disorder seems to be a very important factor for the disappearance of chylothorax.

Identifiants

pubmed: 30626415
doi: 10.1186/s13023-018-0991-3
pii: 10.1186/s13023-018-0991-3
pmc: PMC6327395
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9

Subventions

Organisme : Univerzita Karlova v Praze
ID : PROGRES Q40/08
Pays : International

Références

Arch Bronconeumol. 2011 Jan;47(1):56-7
pubmed: 20952121
AJR Am J Roentgenol. 2001 Apr;176(4):1040-2
pubmed: 11264106
Semin Pediatr Surg. 2014 Oct;23(5):298-302
pubmed: 25459015
J Vasc Interv Radiol. 1999 Oct;10(9):1248-54
pubmed: 10527204
Intern Med J. 2015 Sep;45(9):980-3
pubmed: 26332625
Mayo Clin Proc. 2009 Feb;84(2):129-33
pubmed: 19181646
Interact Cardiovasc Thorac Surg. 2015 Jun;20(6):848-54
pubmed: 25784759
Ann Thorac Surg. 2003 Jul;76(1):231-3
pubmed: 12842547
Br Med Bull. 2005 Mar 14;72:31-47
pubmed: 15767562
Int J Oral Maxillofac Surg. 2004 Dec;33(8):761-5
pubmed: 15556323
J Heart Lung Transplant. 2007 Sep;26(9):953-5
pubmed: 17845935
Respir Med. 2010 Jan;104(1):1-8
pubmed: 19766473
Mayo Clin Proc. 2005 Jul;80(7):867-70
pubmed: 16007891
Turk J Pediatr. 2015 Mar-Apr;57(2):195-7
pubmed: 26690606
Ann Surg. 1973 Feb;177(2):245-9
pubmed: 4698540
Chest. 2007 Nov;132(5):1584-90
pubmed: 17890482
Ann Thorac Cardiovasc Surg. 2011;17(1):63-6
pubmed: 21587132
Case Rep Hematol. 2014;2014:684689
pubmed: 24891961
Hematol Oncol. 2009 Jun;27(2):71-81
pubmed: 19266491
Eur J Cancer Care (Engl). 2012 Sep;21(5):599-605
pubmed: 22309398
Br J Radiol. 2009 Apr;82(976):286-90
pubmed: 19029221
Br J Community Nurs. 2014 Oct;Suppl Nutrition:S6-8
pubmed: 25381927
Tex Heart Inst J. 2012;39(3):428-30
pubmed: 22719161
Rev Med Chil. 2005 Dec;133(12):1473-6
pubmed: 16446875
Curr Opin Pulm Med. 2013 Jul;19(4):380-6
pubmed: 23715291
Dtsch Arztebl Int. 2013 Nov 29;110(48):819-26
pubmed: 24333368
Ann Am Thorac Soc. 2017 Jun;14(6):976-985
pubmed: 28326798
Eur J Cardiothorac Surg. 2008 Mar;33(3):435-9
pubmed: 18207415
Chest. 1998 Jul;114(1):154-9
pubmed: 9674463
Strahlenther Onkol. 2008 Sep;184(9):484-7
pubmed: 19016028
Respiration. 2014;88(1):74-85
pubmed: 24853298
Indian J Radiol Imaging. 2012 Apr;22(2):89-92
pubmed: 23162248
Chest. 2013 Jan;143(1):158-163
pubmed: 22797603

Auteurs

Jana Pospiskova (J)

4th Department of Internal Medicine - Hematology, University Hospital, Sokolska Street 581, 5005, Hradec Kralove, Czech Republic.

Lukas Smolej (L)

4th Department of Internal Medicine - Hematology, University Hospital, Sokolska Street 581, 5005, Hradec Kralove, Czech Republic.
Faculty of Medicine in Hradec Králové, Charles University Prague, Hradec Kralove, Czech Republic.

David Belada (D)

4th Department of Internal Medicine - Hematology, University Hospital, Sokolska Street 581, 5005, Hradec Kralove, Czech Republic.
Faculty of Medicine in Hradec Králové, Charles University Prague, Hradec Kralove, Czech Republic.

Martin Simkovic (M)

4th Department of Internal Medicine - Hematology, University Hospital, Sokolska Street 581, 5005, Hradec Kralove, Czech Republic.
Faculty of Medicine in Hradec Králové, Charles University Prague, Hradec Kralove, Czech Republic.

Monika Motyckova (M)

4th Department of Internal Medicine - Hematology, University Hospital, Sokolska Street 581, 5005, Hradec Kralove, Czech Republic.
Faculty of Medicine in Hradec Králové, Charles University Prague, Hradec Kralove, Czech Republic.

Alice Sykorova (A)

4th Department of Internal Medicine - Hematology, University Hospital, Sokolska Street 581, 5005, Hradec Kralove, Czech Republic.

Pavla Stepankova (P)

4th Department of Internal Medicine - Hematology, University Hospital, Sokolska Street 581, 5005, Hradec Kralove, Czech Republic.

Pavel Zak (P)

4th Department of Internal Medicine - Hematology, University Hospital, Sokolska Street 581, 5005, Hradec Kralove, Czech Republic. pavel.zak@fnhk.cz.
Faculty of Medicine in Hradec Králové, Charles University Prague, Hradec Kralove, Czech Republic. pavel.zak@fnhk.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH